What does leaky gut mean?

What does leaky gut mean?

The intestine is lined with a single layer of epithelial cells held together by so‑called tight junctions, proteins that determine how much is allowed to pass from the intestinal lumen into the blood. When these structures are damaged, intestinal permeability increases, sometimes called “leaky gut,” allowing bacterial components, toxins, and incompletely digested foods to pass through more easily and trigger the immune system. Increased permeability has been demonstrated in, among other things, inflammatory bowel disease, IBS, infections, NSAID use, intense exercise, and vitamin D deficiency, but it is a matter of degree, not a binary state.

Why does leaky gut occur? 

Leaky gut (increased intestinal permeability) arises when the otherwise tight barrier in the small intestine is damaged so that the tight junctions between epithelial cells open more than they should. Then bacteria, toxins, and incompletely broken‑down food molecules can pass into the blood and trigger the immune system, which drives inflammation and sometimes autoimmune processes. The most important causes are:

Diet and gut microbiota

High sugar, ultra‑processed food, alcohol, and inappropriate fiber intake promote dysbiosis (an imbalanced gut microbiota) that produces toxins and inflammatory signals that damage the mucosa. Gluten and certain dietary lectins can, in susceptible individuals, increase zonulin, a protein that opens tight junctions and thereby increases permeability.

Infections, SIBO, and toxins

Bacterial infections, parasites, and small intestinal bacterial overgrowth (SIBO) can directly damage the epithelial cells or their mucosa and increase the production of inflammatory cytokines. Bacterial toxins and bile salts during diarrhea also contribute to breakdown of the barrier.

Medications and alcohol

NSAIDs (e.g., ibuprofen), certain medications, corticosteroids, and long‑term high alcohol consumption are well known to disrupt mucosal integrity and loosen tight junctions. This can produce a measurable increase in intestinal permeability even after a short period of use in susceptible individuals.

Chronic stress and sleep deprivation

Prolonged elevated cortisol, overactivation of the sympathetic nervous system and poor sleep affect immune regulation and blood flow in the gut, which impairs regeneration of epithelial cells and makes the barrier heal more poorly after injury. This creates a vicious cycle in which inflammation and permeability sustain each other.

Nutrient deficiencies and systemic inflammation

Deficiency of, for example, zinc, vitamin D, certain B vitamins, omega‑3s, and amino acids prevents enterocytes from renewing normally and tight junction proteins from being synthesized optimally. Concurrent low‑grade inflammation from other organs (e.g., adipose tissue in metabolic syndrome) amplifies the damage to the barrier.

Glutamine: fuel and building block for the intestinal mucosa

Enterocytes (intestinal epithelial cells) use L‑glutamine as their primary fuel and as a substrate to build new cells and tight junction proteins. Acute, short‑term intervention studies show that glutamine supplementation can reduce markers of intestinal permeability and cell damage during strenuous physical exertion and heat stress, as well as in clinical situations with pronounced stress on the intestine. For people with suspected leaky gut, L‑glutamine is often used daily in cycles, even though long‑term data in healthy individuals are still limited.

Zinc: support for intestinal epithelium and tight junctions

Zinc is necessary for cell proliferation, antioxidant defense, and enzymatic activity in the intestinal mucosa, and deficiency is linked to impaired barrier function and longer healing time in intestinal irritation. Zinc is a cofactor for over 300 enzymes, including those that build tight junction proteins and regenerate epithelial cells. Deficiency impairs the barrier, increases zonulin, and prolongs the inflammatory phase after injury. Studies show that daily zinc supplementation improves barrier function in alcohol‑induced damage or IBD.

Probiotics and postbiotics: the microbiota as a barrier regulator

The gut microbiota influences barrier function via production of short‑chain fatty acids (especially butyrate), modulation of the immune system, and direct effects on tight junctions. A multi‑strain probio­tic with various Lactobacillus and Bifidobacterium strains reduces intestinal permeability and normalizes it in 37–44% of IBS‑D patients with objectively measured leaky gut after 30 days of treatment, while abdominal pain, diarrhea, and quality of life improve according to research. 

Vitamin D: hormonal regulation of tight junctions

The vitamin D receptor is expressed in the intestinal mucosa and regulates expression of several key tight junction proteins such as ZO‑1, claudin‑1, and E‑cadherin. Animal experiments show that mice without a vitamin D receptor develop a markedly impaired barrier, more inflammation, and more severe colitis, whereas active vitamin D improves transepithelial resistance and protects against injury by strengthening tight junctions and the healing capacity of epithelial cells. Observational data in humans link vitamin D deficiency to increased risk of IBD and gut dysfunction, which supports optimizing 25‑OH‑D levels.

Omega‑3 fatty acids – anti‑inflammatory protection of the barrier

Long‑chain omega‑3 fatty acids (EPA and DHA) from fish oil have both anti‑inflammatory effects and direct effects on cell membranes and tight junctions. A randomized study linked to a Mediterranean diet showed that an increased proportion of omega‑3 in plasma improved markers of intestinal barrier function after 3–12 months, suggesting that both diet and targeted omega‑3 supplementation can reduce low‑grade “leakage” inflammation. The effect is particularly interesting in metabolic syndrome, IBS, and low‑grade systemic inflammation.

Digestive enzymes: reduced load on the intestinal mucosa

Digestive enzymes such as proteases, lipases, and amylases break down proteins, fats, and carbohydrates into smaller molecules that are more easily absorbed without irritating the intestinal wall. Incomplete breakdown of gluten, casein, and complex carbohydrates (FODMAPs) can increase zonulin production and loosen tight junctions, which worsens leaky gut. Clinical studies on enzyme supplementation in IBS and food intolerance show reduced gas formation, abdominal pain, and improved nutrient absorption, as the enzymes compensate for insufficient endogenous production and reduce the number of irritating particles reaching the small intestine. This gives the intestinal mucosa a better chance to heal by removing a primary cause of local inflammation and barrier damage.

Polyphenols: modulation of inflammation and tight junctions

Polyphenols in general interact with the microbiota and can increase production of short‑chain fatty acids, which further supports barrier function, although dose–response in humans is still poorly mapped.

Resveratrol: polyphenol from grapes

Resveratrol from grape skins is a stilbene polyphenol with anti‑inflammatory effects that stabilizes the intestinal barrier. In vitro models show that resveratrol protects epithelial cells from LPS‑ and cytokine‑induced damage by dampening NF‑κB activation and preserving tight junction structure (ZO‑1, occludin), which reduces IL‑6/IL‑8 production and leakage. Polyphenols in general interact with the microbiota and can increase production of short‑chain fatty acids, which further supports barrier function, although dose–response in humans is still poorly mapped.

Quercetin flavonoid polyphenol

Quercetin from onions and berries is a flavonoid polyphenol with anti‑inflammatory effects that strengthens the intestinal barrier. In vitro models show that quercetin protects epithelial cells from oxidative stress and cytokine‑induced damage by stabilizing tight junctions (claudin‑1, occludin) and reducing zonulin, which counteracts leakage. Polyphenols in general interact with the microbiota and can increase production of short‑chain fatty acids, which further supports barrier function, although dose–response in humans is still poorly mapped

Author